Objective: To analyze the prevalence of abdominal obesity and associated factors in quilombola communities in Northern Minas Gerais, Brazil.
Methods: This was a cross-sectional study conducted in 2019 through structured interviews and waist circumference measurement; Poisson regression was used, separated by gender, to calculate prevalence ratios (PR) of abdominal obesity adjusted by independent variables and 95% confidence interval (95%CI).
Results: 56.6% (95% CI 50.9;62.0) of the observed quilombolas presented abdominal obesity; in the adjusted analysis, among men, there was an association of the outcome with age ≥60 years old (60-69 years old: PR=2.52 - CI95% 1.33; 4.75), not being a smoker (PR=1.73 - 95%CI 1.17;2.55) and reported arterial hypertension (PR=1.42 - 95%CI 1.11;1.80), while in women, it was associated with age ≥50 years old (50-59 years old: PR=1.25 - 95% CI 1.01;1.54), smoking cessation (PR=1.26 - 95% CI 1.00; 1.58), consumption of chicken with skin (PR=1.09 - 95% CI 1.00;1.19) and hypertension (PR=1.22 - 95% CI 1.11;1.36).
Conclusion: There was high prevalence of abdominal obesity among quilombolas. It was higher in the elderly, smokers, former smokers and those with hypertension.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1590/S1679-49742021000300023 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Dosing optimisation of intravenous lidocaine in patients with class 1-3 obesity by population pharmacokinetic analysis.
Anaesthesia
January 2025
Department of Anaesthesia and Perioperative Medicine, The Royal Brisbane and Women's Hospital, Brisbane, Australia.
Introduction: Evidence to support intra-operative lidocaine infusion regimens in patients with obesity is lacking, risking underdosing or toxicity. We aimed to measure the plasma concentrations of lidocaine and its active metabolites to develop a pharmacokinetic model and optimised dosing regimen in patients with obesity.
Methods: A standardised weight-based intravenous lidocaine regimen was administered to patients with a BMI ≥ 30 kg.
The association between the body roundness index and the risk of chronic kidney disease in US adults.
Front Med (Lausanne)
December 2024
Department of Cardiology, The Third Hospital of Mianyang/Sichuan Mental Health Center, Mianyang, Sichuan, China.
Aim: We aimed to systematically assess whether the level of body roundness index (BRI) is associated with the risk of developing chronic kidney disease (CKD) in US adults.
Methods: The studied data was extracted from the National Health and Nutrition Examination Survey (NHANES) spanning from 1999 to 2018. A total of 29,062 participants aged ≥20 years with complete information about BRI and CKD were included in this study.
Background And Objectives: Metabolic disease has become a global health concern, and insulin resistance (IR) is a crucial underlying mechanism in various metabolic diseases. This study aims to compare the ability of seven anthropometric indicators in predicting IR in the Chinese population, and to find more sensitive and simple anthropometric indicator for early identification of IR.
Methods: This prospective cross-sectional study obtained participants' medical history, anthropometric indicators, and serum samples from three hospitals in China.
Predicting Severity of Acute Pancreatitis-Evaluation of Neutrophil-to-Lymphocyte Count Ratio as Emerging Biomarker: A Retrospective Analytical Study.
Cureus
November 2024
General Surgery, Sri Devaraj Urs Medical College, Kolar, IND.
Introduction Acute pancreatitis (AP) is a pancreatic inflammatory disease that can range in severity from mild, self-limiting forms to severe cases with high mortality rates. AP has various etiologies, including lifestyle factors like alcohol consumption and obesity, and its rapid progression makes early and accurate prediction of severity critical for effective management and improved patient outcomes. The traditional AP severity assessment tools, such as Ranson's criteria and APACHE II, require extensive data and time, making them less feasible in emergency settings.
View Article and Find Full Text PDFBackground: A significant proportion of hypertensive patients also suffer from comorbid dyslipidemia, which critically influences their treatment outcomes and overall prognosis. Given its implications, the lipid profiles of hypertensive individuals warrant increased attention for more effective clinical management.
Methods: We analyzed data from 92,443 hypertensive patients registered at primary community health institutions in 2021.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!